Paper90168
Phosphonoformate inhibition of visna virus replication.
Sundquist B and 1 other. J Virol, 1979. Cited by 25 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Phosphonoformate inhibition of visna virus replication. Papers, record 90168. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/90168
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Organophosphorus Compounds | Major topic |
| Phosphonoacetic Acid | Major topic |
| Virus Replication | Major topic |
| Visna-maedi virus | Major topic |
| Animals | |
| Cell Line | |
| Choroid Plexus | |
| Cytopathogenic Effect, Viral | |
| Reverse Transcriptase Inhibitors | |
| Sheep |
Source PubMed
References9
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 2 | 185,798 | Membrane changes associated with assembly of visna virus. | Virology | 1976 | https://conductscience.org/library/papers/185798 | PubMed |
| 3 | 198,587 | Visna virus RNA synthesis. | J Virol | 1977 | https://conductscience.org/library/papers/198587 | PubMed |
| 4 | 206,200 | Inhibition of herpesvirus replication and herpesvirus-induced deoxyribonucleic acid polymerase by phosphonoformate. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/206200 | PubMed |
| 5 | 210,500 | Trisodium phosphonoformate, a new antiviral compound. | Science | 1978 | https://conductscience.org/library/papers/210500 | PubMed |
| 6 | 280,146 | Selective inhibition of RNA tumor virus replication in vitro and evaluation of candidate antiviral agents in vivo. | Ann N Y Acad Sci | 1977 | https://conductscience.org/library/papers/280146 | PubMed |
| 7 | 4,316,300 | RNA-dependent DNA polymerase in virions of RNA tumour viruses. | Nature | 1970 | https://conductscience.org/library/papers/4316300 | PubMed |
| 8 | 4,316,301 | RNA-dependent DNA polymerase in virions of Rous sarcoma virus. | Nature | 1970 | https://conductscience.org/library/papers/4316301 | PubMed |
| 9 | 56,255 | The slow infection caused by visna virus. | Curr Top Microbiol Immunol | 1975 | https://conductscience.org/library/papers/56255 | PubMed |
| 10 | 727,763 | Reversible effects on cellular metabolism and proliferation by trisodium phosphonoformate. | Antimicrob Agents Chemother | 1978 | https://conductscience.org/library/papers/727763 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7,509,142 | Inhibition of visna virus replication by 2',3'-dideoxynucleosides and acyclic nucleoside phosphonate analogs. | Antimicrob Agents Chemother | 1993 | https://conductscience.org/library/papers/7509142 | PubMed |
| 7,046,399 | The significance of NT1, NT2, and NT3 antigens in epidemiological investigations of bovine group-B streptococcus infections. | Acta Vet Scand | 1981 | https://conductscience.org/library/papers/7046399 | PubMed |
| 6,178,013 | Differential inhibition of DNA polymerase and RNase H activities of the reverse transcriptase by phosphonoformate. | Mol Cell Biochem | 1982 | https://conductscience.org/library/papers/6178013 | PubMed |
| 6,166,282 | Goat visna virus: isolation of a retrovirus related to visna virus of sheep. | Arch Virol | 1981 | https://conductscience.org/library/papers/6166282 | PubMed |
| 3,435,102 | Novel pyrazolo[3,4-d]pyrimidine nucleoside analog with broad-spectrum antiviral activity. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3435102 | PubMed |
| 2,942,386 | Antiviral drugs for AIDS. Current status and future prospects. | Drugs | 1986 | https://conductscience.org/library/papers/2942386 | PubMed |
| 2,824,170 | Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date. | Drugs | 1987 | https://conductscience.org/library/papers/2824170 | PubMed |
| 2,680,436 | Antiviral therapy in human immunodeficiency virus infection. | Drugs | 1989 | https://conductscience.org/library/papers/2680436 | PubMed |
| 2,445,282 | Visna virus as an in vitro model for human immunodeficiency virus and inhibition by ribavirin, phosphonoformate, and 2',3'-dideoxynucleosides. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/2445282 | PubMed |
| 2,425,731 | PPi analogs as inhibitors of human T-lymphotropic virus type III reverse transcriptase. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/2425731 | PubMed |
| 2,141,779 | Age-related differences in pharmacokinetics of phosphonoformate in cats. | Antimicrob Agents Chemother | 1990 | https://conductscience.org/library/papers/2141779 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/90168
GET https://conductscience.org/api/papers/v1/90168/authors